Analysts Set Expectations for TARA FY2026 Earnings
Protara Therapeutics, Inc. (NASDAQ:TARA – Free Report) – Stock analysts at Cantor Fitzgerald issued their FY2026 earnings per share (EPS) estimates for shares of Protara Therapeutics in a research report issued to clients and investors on Monday, June 9th. Cantor Fitzgerald analyst L. Watsek forecasts that the company will post earnings of ($1.45) per share […]
